Aleph Zero will work alongside the world’s largest telecommunications organizations to help to develop standardized blockchain APIs for the industry Aleph Zero, a blockchain ecosystem engineered ...

In this article, we are going to take a look at where Novartis AG (NYSE:NVS) stands against the other stocks on Jim Cramer’s radar. Jim Cramer often reflects on how he would reform the American ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

AlephYa Education (“AlephYa” or “Company”), a leading pan-GCC education provider, today announced a majority investment from TA Associates (“TA”), a leading global private equity firm ...

The trial compared the efficacy of Novartis’ Leqvio as a single agent against ezetimibe and a placebo. Credit: VILTVART/Shutterstock. Novartis has revealed that its Phase III V-MONO clinical trial of ...

Three years after launching Leqvio in the U.S., Novartis is still steadily advancing its blockbuster ambitions for the cholesterol-lowering drug. Early Wednesday, the company touted phase 3 ...

Novartis has formed a strategic collaboration with drug delivery specialist Lindy Biosciences to develop self-administered versions of the Swiss pharma’s innovative drugs. For $20 million ...

Novartis and other drugmakers have invested in radiopharmaceuticals to treat cancer. The programs require a supply of radioactive compounds that must be produced close to patients because they have ...

No­var­tis is sell­ing off its mol­e­c­u­lar imag­ing busi­ness for positron emis­sion to­mog­ra­phy (PET) scans to Siemens Health­i­neers for an undis­closed amount, both com­pa ...

Siemens Healthineers aims to grow its PET imaging business by picking up the radiodiagnostic manufacturing and distribution network of Novartis’ Advanced Accelerator Applications division.

Learn More Aleph Alpha, a German artificial intelligence startup, released two new large language models (LLMs) under an open license on Monday, potentially reshaping the landscape of AI development.

Novartis confirmed that it has received a binding offer from Siemens Healthineers to buy its molecular imaging business for an undisclosed amount. The Swiss pharma major said Monday that the ...